Men could soon be offered quick MRI scans lasting under 15 minutes to detect prostate cancer earlier, under new recommendations from international experts.

A new study led by researchers at The University of Texas MD Anderson Cancer Center found that prostate cancer patients with low testosterone levels may have a higher risk of cancer progressing to a ...

A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...

Vanquish uses ultrasound, transurethral and electromagnetically guided thermotherapy to ablate prostate tissue.

The government has approved a new update of the list of free and reimbursed medicines, one of the most extensive in recent years. According to the announcement made by the Minister of Health, ...

Medical inflation has steadily outpaced general inflation for years, with bills for many brief, routine procedures reaching tens of thousands of dollars.

The Prostate Cancer Foundation (PCF) today announced the recipients of its 2025 Challenge Awards, providing over $12 million in funding for 12 multi-institutional, cross-disciplinary research teams ...

Philadelphia jury orders Johnson & Johnson to pay damages in a talc related ovarian cancer case, the first plaintiff win ...

A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that adding hormone therapy to postoperative radiotherapy may provide little survival benefit for most men ...

Meta said its multiyear deal with AMD involves deploying up to 6 gigawatts of the company's graphics processing units for AI data centers. Last week, Meta committed to using millions of Nvidia's ...

In the real-world, Pluvicto™ showed 13.5 months median PFS in chemo-naïve patients with PSMA-positive mCRPC Real‑world evidence showed Pluvicto achieved longer PFS when initiated after one ARPI ...